Pages that link to "Q39980054"

The following pages link to A series of potent and selective, triazolylphenyl-based histone deacetylases inhibitors with activity against pancreatic cancer cells and Plasmodium falciparum (Q39980054):

Displaying 35 items.

• Small molecule inhibitors of zinc-dependent histone deacetylases (Q26824515) (← links)
• Histone deacetylase 6 plays a role as a distinct regulator of diverse cellular processes (Q26830233) (← links)
• Exploration of Novel Inhibitors for Class I Histone Deacetylase Isoforms by QSAR Modeling and Molecular Dynamics Simulation Assays (Q28550025) (← links)
• Conformationally homogeneous heterocyclic pseudotetrapeptides as three-dimensional scaffolds for rational drug design: receptor-selective somatostatin analogues (Q33415526) (← links)
• Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group (Q33637372) (← links)
• A novel HDAC inhibitor with a hydroxy-pyrimidine scaffold (Q33940304) (← links)
• Synthesis and biological evaluation of triazol-4-ylphenyl-bearing histone deacetylase inhibitors as anticancer agents (Q34055631) (← links)
• Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells (Q35096555) (← links)
• Discovery of histone deacetylase 8 selective inhibitors (Q36111962) (← links)
• Insights from comprehensive multiple receptor docking to HDAC8. (Q36590450) (← links)
• HDAC6 and ovarian cancer (Q36913610) (← links)
• Drug inhibition of HDAC3 and epigenetic control of differentiation in Apicomplexa parasites (Q37273333) (← links)
• Binding ensemble profiling with photoaffinity labeling (BEProFL) approach: mapping the binding poses of HDAC8 inhibitors (Q37463122) (← links)
• Histone deacetylase inhibitors (HDACIs). Structure--activity relationships: history and new QSAR perspectives (Q37693855) (← links)
• Pharmacological significance of triazole scaffold (Q37768161) (← links)
• Small-molecule chromatin-modifying agents: therapeutic applications (Q37961728) (← links)
• HDAC inhibitors in parasitic diseases (Q37962336) (← links)
• Therapeutic potential of isoform selective HDAC inhibitors for the treatment of schizophrenia (Q38136307) (← links)
• Histone deacetylase 6 in health and disease (Q38357741) (← links)
• The application of click chemistry in the synthesis of agents with anticancer activity (Q38384986) (← links)
• Synthesis of Rapamycin Derivatives Containing the Triazole Moiety Used as Potential mTOR-Targeted Anticancer Agents (Q38772976) (← links)
• The synthesis, antiviral, cytostatic and cytotoxic evaluation of a new series of acyclonucleotide analogues with a 1,2,3-triazole linker (Q39064037) (← links)
• Synthesis and biological evaluation of novel 1,2,3-triazolonucleotides (Q39191262) (← links)
• Design, synthesis, antiviral, and cytotoxic evaluation of novel phosphonylated 1,2,3-triazoles as acyclic nucleotide analogues (Q39374792) (← links)
• Use of the nitrile oxide cycloaddition (NOC) reaction for molecular probe generation: a new class of enzyme selective histone deacetylase inhibitors (HDACIs) showing picomolar activity at HDAC6. (Q39959003) (← links)
• Antimalarial activity of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors (Q41838047) (← links)
• Synthesis of a new series of phosphonylated 1,2,3-triazoles as acyclic analogs of ribavirin (Q42277516) (← links)
• Studies of benzamide- and thiol-based histone deacetylase inhibitors in models of oxidative-stress-induced neuronal death: identification of some HDAC3-selective inhibitors (Q46058932) (← links)
• Structure-activity relationships of hydroxamate-based histone deacetylase-8 inhibitors: reality behind anticancer drug discovery. (Q47357144) (← links)
• Targeted Gene Repression Using Novel Bifunctional Molecules to Harness Endogenous Histone Deacetylation Activity. (Q47599592) (← links)
• Discovery of potent HDAC inhibitors based on chlamydocin with inhibitory effects on cell migration. (Q54523252) (← links)
• Docking-enabled pharmacophore model for histone deacetylase 8 inhibitors and its application in anti-cancer drug discovery (Q85092944) (← links)
• HDAC6-an Emerging Target Against Chronic Myeloid Leukemia? (Q89511232) (← links)
• Structure-Activity and Structure-Toxicity Relationships of Peptoid-Based Histone Deacetylase Inhibitors with Dual-Stage Antiplasmodial Activity (Q91143334) (← links)
• One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites (Q91665347) (← links)